UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations

American journal of physiology: endocrinology and metabolism, 2015-01, Vol.308 (1), p.E1-E20

2015

Volltextzugriff (PDF)

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism

BMJ open diabetes research & care, 2020-03, Vol.8 (1), p.e000871

2020

Volltextzugriff (PDF)

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action

PloS one, 2019-06, Vol.14 (6), p.e0217526-e0217526

2019

Volltextzugriff (PDF)

Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients

Journal of the American Heart Association, 2018-12, Vol.7 (24), p.e009876

2018

Volltextzugriff (PDF)

Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action

PloS one, 2013-02, Vol.8 (2), p.e57458-e57458

2013

Volltextzugriff (PDF)

The storage stability and concentration of acetoacetate differs between blood fractions

Clinica chimica acta, 2014-06, Vol.433, p.278-283

2014

Volltextzugriff (PDF)

TG-interacting factor 1 acts as a transcriptional repressor of sterol O-acyltransferase 2[S]

Journal of lipid research, 2014-04, Vol.55 (4), p.709-717

2014

Volltextzugriff (PDF)

HNF1α and SREBP2 are important regulators of NPC1L1 in human liver

Journal of lipid research, 2010-06, Vol.51 (6), p.1354-1362

2010

Volltextzugriff (PDF)

Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis

Physiological reports, 2020-07, Vol.8 (13), p.e14482-n/a

2020

Volltextzugriff (PDF)

Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men

The journal of clinical endocrinology and metabolism, 2015-12, Vol.100 (12), p.4425-4433

2015

Volltextzugriff (PDF)

Abstract 10013: PRDs Are Multifunctional Oral Inhibitors of PCSK9 and ACAT2

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1)

2021

Volltextzugriff (PDF)

Control of ACAT2 liver expression by HNF1

Journal of lipid research, 2005-09, Vol.46 (9), p.1868-1876

2005

Volltextzugriff (PDF)

Fasting Plasma Insulin Concentrations Are Associated With Changes in Hepatic Fatty Acid Synthesis and Partitioning Prior to Changes in Liver Fat Content in Healthy Adults

Diabetes (New York, N.Y.), 2016-07, Vol.65 (7), p.1858-1867

2016

Volltextzugriff (PDF)

Role of thyroid receptor β in lipid metabolism

Biochimica et biophysica acta, 2011-08, Vol.1812 (8), p.929-937

2011

Volltextzugriff (PDF)

Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection

Arteriosclerosis, thrombosis, and vascular biology, 2016-05, Vol.36 (5), p.817-824

2016

Volltextzugriff (PDF)

In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum

Physiological reports, 2017-12, Vol.5 (24), p.e13532-n/a

2017

Volltextzugriff (PDF)

Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers

The American journal of clinical nutrition, 2019-02, Vol.109 (2), p.260-268

2019

Volltextzugriff (PDF)

Soat2 ties cholesterol metabolism to β‐oxidation and glucose tolerance in male mice

Journal of internal medicine, 2022-08, Vol.292 (2), p.296-307

2022

Volltextzugriff (PDF)

Role of TG-interacting factor (Tgif) in lipid metabolism

Biochimica et biophysica acta, 2015-01, Vol.1851 (1), p.9-12

2015

Volltextzugriff (PDF)

Overexpression of transforming growth factor β induced factor homeobox 1 represses NPC1L1 and lowers markers of intestinal cholesterol absorption

Atherosclerosis, 2018-08, Vol.275, p.246-255

2018

Volltextzugriff (PDF)

Generation of new hepatocyte-like in vitro models better resembling human lipid metabolism

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020-06, Vol.1865 (6), p.158659-158659, Article 158659

2020

Volltextzugriff (PDF)

Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism

Biochimica et biophysica acta, 2016-01, Vol.1861 (1), p.51-59

2016

Volltextzugriff (PDF)

Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport

World journal of gastroenterology : WJG, 2010-12, Vol.16 (47), p.5958-5964

2010

Volltextzugriff (PDF)

Abstract 15537: Ezetimibe in Combination With Simvastatin Reduces Remnant-cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A15537-A15537

2015

Volltextzugriff (PDF)

Abstract 15393: Cholesterol Esterifying Enzyme Acat2 - A Target for Cardiometabolic Diseases

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A15393-A15393

2015

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(35)
Dissertationen
(1)

Sprache

Englisch
(36)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action

Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients

Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action

The storage stability and concentration of acetoacetate differs between blood fractions

TG-interacting factor 1 acts as a transcriptional repressor of sterol O-acyltransferase 2[S]

HNF1α and SREBP2 are important regulators of NPC1L1 in human liver

Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis

Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men

Abstract 10013: PRDs Are Multifunctional Oral Inhibitors of PCSK9 and ACAT2

Control of ACAT2 liver expression by HNF1

Fasting Plasma Insulin Concentrations Are Associated With Changes in Hepatic Fatty Acid Synthesis and Partitioning Prior to Changes in Liver Fat Content in Healthy Adults

Role of thyroid receptor β in lipid metabolism

Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection

In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum

Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers

Soat2 ties cholesterol metabolism to β‐oxidation and glucose tolerance in male mice

Role of TG-interacting factor (Tgif) in lipid metabolism

Overexpression of transforming growth factor β induced factor homeobox 1 represses NPC1L1 and lowers markers of intestinal cholesterol absorption

Generation of new hepatocyte-like in vitro models better resembling human lipid metabolism

Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism

Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport

Abstract 15537: Ezetimibe in Combination With Simvastatin Reduces Remnant-cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients

Abstract 15393: Cholesterol Esterifying Enzyme Acat2 - A Target for Cardiometabolic Diseases

Suchergebnisse filtern